尼泊尔的药物警戒活动。 - Suppr

Pharmacovigilance activities in Nepal.

作者信息

Palaian Subish, Mohamed Ibrahim Mohamed Izham, Mishra Pranaya, Alam Kadir, Shankar Pathiyil Ravi, Thapa Bhupendra Bahadur

出版信息

Drug Saf. 2010 Oct 1;33(10):889-90. doi: 10.2165/11532480-000000000-00000.

DOI:10.2165/11532480-000000000-00000

PMID:20812773

Abstract

摘要

相似文献

Pharmacovigilance activities in Nepal.

Drug Saf. 2010 Oct 1;33(10):889-90. doi: 10.2165/11532480-000000000-00000.

Pharmacovigilance: Importance, concepts, and processes.

Am J Health Syst Pharm. 2017 Apr 15;74(8):606-612. doi: 10.2146/ajhp151031. Epub 2017 Feb 24.

Pharmacovigilance: urgent need in midwestern region of Nepal.

Kathmandu Univ Med J (KUMJ). 2009 Oct-Dec;7(28):470. doi: 10.3126/kumj.v7i4.2776.

What do stakeholders think about pharmacovigilance?

Drug Saf. 2010 Aug 1;33(8):619-21. doi: 10.2165/11539210-000000000-00000.

Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods.

Joint Bone Spine. 2006 Dec;73(6):629-32. doi: 10.1016/j.jbspin.2006.09.002. Epub 2006 Oct 12.

Reporting adverse effects: a practice to be encouraged.

Prescrire Int. 2013 Mar;22(136):83.

Thoughts on signal detection in pharmacovigilance.

Drug Saf. 2007;30(7):603-6. doi: 10.2165/00002018-200730070-00005.

Pharmacovigilance: methods, recent developments and future perspectives.

Eur J Clin Pharmacol. 2008 Aug;64(8):743-52. doi: 10.1007/s00228-008-0475-9. Epub 2008 Jun 4.

Evolving paradigms in pharmacovigilance.

Curr Drug Saf. 2006 May;1(2):127-34. doi: 10.2174/157488606776930599.

[Safety of medicinal products and reporting of adverse drug reactions].

Neurol Neurochir Pol. 2004 Nov-Dec;38(6):503-10.

引用本文的文献

Bibliometric analysis of adverse drug reactions and pharmacovigilance research activities in Nepal.

Ther Adv Drug Saf. 2020 Jun 12;11:2042098620922480. doi: 10.1177/2042098620922480. eCollection 2020.

本文引用的文献

Pharmacovigilance activities in 55 low- and middle-income countries: a questionnaire-based analysis.

Drug Saf. 2010 Aug 1;33(8):689-703. doi: 10.2165/11536390-000000000-00000.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Pharmacovigilance activities in Nepal.

Drug Saf. 2010 Oct 1;33(10):889-90. doi: 10.2165/11532480-000000000-00000.

Pharmacovigilance: Importance, concepts, and processes.

Am J Health Syst Pharm. 2017 Apr 15;74(8):606-612. doi: 10.2146/ajhp151031. Epub 2017 Feb 24.

Pharmacovigilance: urgent need in midwestern region of Nepal.

Kathmandu Univ Med J (KUMJ). 2009 Oct-Dec;7(28):470. doi: 10.3126/kumj.v7i4.2776.

What do stakeholders think about pharmacovigilance?

Drug Saf. 2010 Aug 1;33(8):619-21. doi: 10.2165/11539210-000000000-00000.

Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods.

Joint Bone Spine. 2006 Dec;73(6):629-32. doi: 10.1016/j.jbspin.2006.09.002. Epub 2006 Oct 12.

Reporting adverse effects: a practice to be encouraged.

Prescrire Int. 2013 Mar;22(136):83.

Thoughts on signal detection in pharmacovigilance.

Drug Saf. 2007;30(7):603-6. doi: 10.2165/00002018-200730070-00005.

Pharmacovigilance: methods, recent developments and future perspectives.

Eur J Clin Pharmacol. 2008 Aug;64(8):743-52. doi: 10.1007/s00228-008-0475-9. Epub 2008 Jun 4.

Evolving paradigms in pharmacovigilance.

Curr Drug Saf. 2006 May;1(2):127-34. doi: 10.2174/157488606776930599.

[Safety of medicinal products and reporting of adverse drug reactions].

Neurol Neurochir Pol. 2004 Nov-Dec;38(6):503-10.

引用本文的文献

Bibliometric analysis of adverse drug reactions and pharmacovigilance research activities in Nepal.

Ther Adv Drug Saf. 2020 Jun 12;11:2042098620922480. doi: 10.1177/2042098620922480. eCollection 2020.

本文引用的文献

Pharmacovigilance activities in 55 low- and middle-income countries: a questionnaire-based analysis.

Drug Saf. 2010 Aug 1;33(8):689-703. doi: 10.2165/11536390-000000000-00000.

Pharmacovigilance activities in Nepal.

作者信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献